Hypertrophied right hearts get two for the price of one: Can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)233-235
Number of pages3
JournalCirculation
Volume116
Issue number3
DOIs
StatePublished - Jul 2007

Keywords

  • Cyclic nucleotide phosphodiesterases, type 5
  • Editorials
  • Hypertrophy
  • Nucleotides, cyclic
  • Pharmacology
  • Pulmonary heart disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this